SCHEMBL5709581

SCHEMBL5709581

CCOCCN(C)C(=O)C[C@@H](CCc1ccccc1)C(=O)N[C@](CC)(C(N)=O)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
MMP2 P08253 7/20 0.33
MMP3 P08254 2/20 0.33
MMP1 P03956 2/20 0.33
MMP9 P14780 1/20 0.33
MMP14 P50281 1/20 0.33
FCER2 P06734 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
LTB4R Q15722 2/20 0.32
LTB4R2 Q9NPC1 2/20 0.32
TACR1 P25103 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5709644 0.93 CTSS (0.35) CTSSCTSKMMP2MMP3MMP1
SCHEMBL9556176 0.90 MMP2 (0.35) CTSSCTSKMMP2MMP3MMP1
SCHEMBL9556465 0.87 MMP2 (0.33) CTSSCTSKMMP2MMP3MMP1
SCHEMBL6350291 0.80 CTSS (0.36) CTSSCTSKMMP2MMP3MMP1
SCHEMBL6349373 0.80 HRH4 (0.34) MMP2MMP3
SCHEMBL7322606 0.79 CTSS (0.40) CTSSCTSKMMP2MMP3MMP1
SCHEMBL5709577 0.77 MMP1 (0.38) CTSSCTSKMMP2MMP3MMP1
SCHEMBL9555901 0.75 CTSK (0.46) CTSSCTSKMMP2MMP3MMP1
SCHEMBL5709603 0.74 CTSS (0.39) CTSSCTSKMMP2MMP3MMP1
SCHEMBL9556487 0.72 UTS2R (0.34) CTSKMMP2MMP3MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1712227-A1 Amino diols useful in the treatment of Alzheimer's disease Elan Pharmaceuticals, Inc. (US) 2006-10-18 EP claimed
EP-1712227-A1 Amino diols useful in the treatment of Alzheimer's disease Elan Pharmaceuticals, Inc. (US) 2006-10-18 EP disclosed
WO-1990000051-A1 ETHEREAL N-TERMINAL AMINODIOL AMINO ACID DERIVATIVES AS ANTI-HYPERTENSIVE AGENTS G.D. SEARLE & CO. (US) 1990-01-11 WO disclosed